P-76 Phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD)
N. Sugimoto(Osaka International Cancer Institute), Hiroshi Eguchi(The University of Osaka), Noriyuki Miyoshi(University of Shizuoka), Mamoru Uemura(Osaka International Cancer Institute), Yoshinori Kagawa(Osaka International Cancer Institute), Hirokazu Yamamoto(The University of Osaka), G. Sato(The University of Osaka), Yuichiro� Doki(Osaka Gakuin University), Ken Konishi(Hyogo Prefectural Nishinomiya Hospital), Atsushi naito(Osaka Police Hospital), S. Yoshioka, Hideki Osawa(Osaka Hospital), Hiroshi Tamagawa(Otemae Hospital), Katsuki Danno(The University of Osaka), T. Shimokawa(Wakayama Medical University), M. Tei(Osaka Rosai Hospital), Ken Nakata(Sakai Municipal Hospital), N. Nishida(Osaka International Cancer Institute), H. Takahashi(The University of Osaka), Tatsushi Shingai(Kinki Central Hospital), K. Murata, Masaaki Miyo(Osaka National Hospital)
Cited by 1
Related Papers
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
|Clinical Cancer Research|2011|245
Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in Epithelial Cells
|Journal of Biological Chemistry|2003|231
Tage4/Nectin-like Molecule-5 Heterophilically trans-Interacts with Cell Adhesion Molecule Nectin-3 and Enhances Cell Migration
|Journal of Biological Chemistry|2003|130
Enhancement of Serum- and Platelet-derived Growth Factor-induced Cell Proliferation by Necl-5/Tage4/Poliovirus Receptor/CD155 through the Ras-Raf-MEK-ERK Signaling
|Journal of Biological Chemistry|2004|120